PMID- 22906519 OWN - NLM STAT- MEDLINE DCOM- 20140130 LR - 20220317 IS - 1873-2402 (Electronic) IS - 0006-3223 (Linking) VI - 74 IP - 4 DP - 2013 Aug 15 TI - Altered brain-derived neurotrophic factor expression in the ventral tegmental area, but not in the hippocampus, is essential for antidepressant-like effects of electroconvulsive therapy. PG - 305-12 LID - S0006-3223(12)00651-8 [pii] LID - 10.1016/j.biopsych.2012.07.025 [doi] AB - BACKGROUND: Impaired neuronal plasticity and, specifically, altered expression of brain-derived neurotrophic factor (BDNF) were shown to play a critical role in depressive behavior and the mechanism of various antidepressant treatments including electroconvulsive therapy (ECT). Interestingly, opposing roles were suggested for BDNF in the hippocampus and the ventral tegmental area (VTA), while interactions between these regions were shown on various levels. Here, we evaluated whether BDNF plays an essential role in the antidepressant-like effects of ECT and performed a direct comparison between BDNF manipulations in the VTA and the hippocampus. METHODS: Knockdown or overexpression of BDNF was induced in hippocampus or VTA of rats by microinjection of specific lentiviral vectors. The effects of these manipulations on antidepressant outcomes of ECT were evaluated by the forced swim test and by sucrose preference measurements, and BDNF expression levels were assessed in other reward-related brain regions. RESULTS: Here, we show that whereas ECT increased hippocampal BDNF expression, induction of hippocampal BDNF knockdown did not block its antidepressant-like effect. Importantly, we found that ECT caused a robust reduction in VTA BDNF levels. Moreover, VTA BDNF knockdown alone was sufficient to induce an antidepressant-like effect, and VTA BDNF overexpression blocked the antidepressant-like effect of ECT. CONCLUSIONS: While neuroplastic alterations, as expressed by changes in BDNF expression within different brain regions, are induced by ECT, the antidepressant-like effect of ECT in an animal model depends on reduction of VTA BDNF expression but not on the elevation of hippocampal BDNF expression. CI - Copyright (c) 2013 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved. FAU - Taliaz, Dekel AU - Taliaz D AD - Department of Neurobiology, Weizmann Institute of Science, Rehovot, Israel; Department of Life Science, Ben Gurion University, Beer Sheva, Israel. FAU - Nagaraj, Vini AU - Nagaraj V FAU - Haramati, Sharon AU - Haramati S FAU - Chen, Alon AU - Chen A FAU - Zangen, Abraham AU - Zangen A LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20120817 PL - United States TA - Biol Psychiatry JT - Biological psychiatry JID - 0213264 RN - 0 (Brain-Derived Neurotrophic Factor) SB - IM MH - Animals MH - Brain-Derived Neurotrophic Factor/*metabolism MH - *Electroconvulsive Therapy MH - Hippocampus/*metabolism MH - Male MH - Rats MH - Rats, Sprague-Dawley MH - Ventral Tegmental Area/*metabolism OTO - NOTNLM OT - BDNF OT - ECT OT - VTA OT - depression OT - hippocampus OT - rat model EDAT- 2012/08/22 06:00 MHDA- 2014/01/31 06:00 CRDT- 2012/08/22 06:00 PHST- 2012/04/23 00:00 [received] PHST- 2012/06/25 00:00 [revised] PHST- 2012/07/11 00:00 [accepted] PHST- 2012/08/22 06:00 [entrez] PHST- 2012/08/22 06:00 [pubmed] PHST- 2014/01/31 06:00 [medline] AID - S0006-3223(12)00651-8 [pii] AID - 10.1016/j.biopsych.2012.07.025 [doi] PST - ppublish SO - Biol Psychiatry. 2013 Aug 15;74(4):305-12. doi: 10.1016/j.biopsych.2012.07.025. Epub 2012 Aug 17.